Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer | Breast Cancer Research | Full Text

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer | Breast Cancer Research | Full Text

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understandi...

Authors:Laura A. Baker, Holly Holliday, Daniel Roden, Christoph Krisp, Sunny Z. Wu, Simon Junankar, Aurelien A. Serandour, Hisham Mohammed, Radhika Nair, Geetha Sankaranarayanan, Andrew M. K. Law, Andrea McFarland, Peter T. Simpson, Sunil Lakhani, Eoin Dodson, Christina Selinger…

Citation:Breast Cancer Research 2020 22:63

Content type:Research article

 

Published on: 11 June 2020

• ViewFull Text
 
• ViewPDF